All In Biotech

Drug Trial Radar · NCT04238481

A Study for Ureter Visualization, Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery

A Phase 2 Randomized Open-label, Dose-ranging Study for Ureter Visualization Using ASP5354 in Subjects Undergoing Laparoscopic/Minimally Invasive Colorectal Surgery

Last checked: Nov 20, 2026Latest source record: Oct 24, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registry

Status

Completed

Enrollment

13

Actual

Start

Oct 6, 2020

Primary completion

Nov 18, 2021

Study completion Nov 29, 2021

Sponsor

Lead sponsor
Astellas Pharma IncAstellas (ALPMY)
Sponsor type
Industry
First posted
Jan 23, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Other
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of this study was to determine the optimal dose of ASP5354 for ureter visualization in participants undergoing laparoscopic/minimally invasive colorectal surgery This study also investigated the safety, tolerability and the pharmacokinetics of ASP5354 in participants undergoing laparoscopic/minimally invasive colorectal surgery.

Conditions

  • Laparoscopic/Minimally Invasive Colorectal Surgery

Interventions

  • Pudexacianinium chlorideDrug

    Intravenous

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Participants With Successful Anatomical Visualization of the Index Ureter(s)Time frame: 30 minutes postdose through end of surgery (on day 1)

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • Center for Colon and Rectal Surgery; AdventHealth Medical Group

    Orlando, Florida

  • Ochsner Medical Center

    New Orleans, Louisiana

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.